Yeastone Broth Recall by Remel, Inc.
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Remel, Inc. is voluntarily recalling 2819 units of Yeastone Broth due to potential incorrect AST results, which may lead to delayed medical responses if quality control is ignored.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Remel, Inc. is recalling Yeastone Broth because the products may report incorrect AST results during quality control, potentially leading to delayed responses or the need to switch antifungal agents if the test results are not properly addressed.
Which Products Are Affected
The affected product is Yeastone Broth, 11ML, 10/BOX with catalog number YY3462. The recall involves 2819 units with the following lot numbers: 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, and 311723. This recall applies to products distributed nationwide in the United States and internationally to countries including Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, and Singapore. The official recall number is Z-1806-2026.
What You Should Do
Consumers and laboratories should stop using the affected Yeastone Broth lots immediately and contact Remel, Inc. at their address: 12076 Santa Fe Trail Dr, Lenexa, KS 66215-3519, as the initial notification was made via letter. Follow the firm's instructions for returns or refunds.
Why This Matters
This recall is significant because inaccurate test results could delay appropriate medical treatment, potentially affecting patient outcomes in antifungal therapy.
Source
Attribution: U.S. Food and Drug Administration (FDA). For more information, visit the FDA website at https://www.fda.gov and reference event ID 98616.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,440 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.